All Articles

A landmark gift rebrands LAU's New York campus, creating a global hub to counter Lebanon's talent exodus and foster a new generation of leaders.

With the appointment of Dr. Damian Curtis as R&D head, BioConsortia signals a major push in genomics and gene editing to transform sustainable agriculture.

MAI Capital acquires Dallas-based Service Academy Capital Management, expanding its UHNW division and targeting Texas's booming ultra-wealthy market.

The new fund from Loomis Sayles and Natixis enters the booming interval fund market, offering access to private credit amid growing regulatory scrutiny.

EV platform Spiro lands a massive $215M investment to expand its battery-swapping network, promising cheaper transport and cleaner air across Africa.

Endeavor Health's new genetic test provides a "floodlight" on heart disease risk, but with no insurance coverage, who will get to see the light?

With two key acquisitions and fresh private equity backing, CHR Group is building a digital empire to transform food safety and operations globally.

insightsoftware and TimeXtender unveil a new Jet Analytics, offering a unified data foundation to accelerate cloud adoption and unlock reliable AI insights.

The nail industry leader debuts a groundbreaking Visible Light Lamp, eliminating UV exposure and setting a new standard for performance and safety.

A former boxer who lost his leg after a foot infection was mistreated wins a $6.4M verdict, highlighting failures in care and a trend of large awards.

Early Phase 1 data for APR-1051 reveals anti-tumor activity and manageable safety, offering a new glimmer of hope for patients with advanced solid tumors.

With a new CEO and strong private equity backing, Vālenz Health is poised to accelerate its push into the booming self-funded healthcare market.

Revance unites its top acne treatment, PanOxyl, and microneedling device, SkinPen, in a strategic play to capture the holistic skincare market.

Anixa Biosciences secures a key Canadian patent for its novel ovarian cancer vaccine, advancing a new paradigm in cancer prevention for high-risk women.

After a five-year hiatus, the cult-favorite brand returns with a maximalist new look, challenging the reign of 'clean girl' beauty. Here's what's new.

Celebrating 10 years, Borrowell hits 4M members and 87M credit points gained. But how does its impact stack up in Canada's complex financial world?

A single blood test can now simultaneously track immune response, tumor changes, and resistance, offering new hope for personalizing sarcoma immunotherapy.

MedtechWOMEN's VISION 2026 conference will address the industry's most pressing challenges, featuring leaders like Dr. Bayo Curry-Winchell and Martha Aronson.

A new drug targeting cancer's 'immortality switch' enters a pivotal trial, offering hope for non-small cell lung cancer patients out of options.

The company is set to quadruple its cash-flowing assets in 2026, capitalizing on soaring demand for copper and tin essential for the energy transition.